Retail investors largely ignored the government’s offer for sale in IRFC, with only a fraction of the reserved shares being bid for on the final day. Institutional investors had previously subscribed to nearly 95% of their allocated shares. Due to undersubscription, the government opted not to exercise the green-shoe option.
Pharma, Auto, and IT: Pankaj Pandey shares sectoral insights amid global challenges
Pankaj Pandey shares insights on Indian sectors facing US tariffs. He sees limited impact on pharma growth but potential benefits for Jubilant Pharma and Piramal